Use of an integrated strip-free blood glucose monitoring system increases frequency of self-monitoring and improves glycemic control: Results from the ExAct study

Maran, Alberto;Tschoepe, Diethelm;Di Mauro, Maurizio;Fisher, William A.;Cranston, Iain;et.al.
(2014) Journal of Clinical and Translational Endocrinology — Vol. 1, n° 4, p. 161-166 (2014)

Files

No attached file found for this publication.

Details

Authors
  • Maran, Alberto
    Author
  • Tschoepe, Diethelm
    Author
  • Di Mauro, Maurizio
    Author
  • Fisher, William A.
    Author
  • Kohut, Taylororcid-logoUCLouvain
    Author
  • Cranston, Iain
    Author
Show more
Abstract
Aims We investigated the impact of using an integrated, strip-free system compared to the use of single-strip systems on testing frequency and glycemic control in individuals with insulin-treated diabetes. Methods This multinational, comparative, cluster-randomized, observational study included 311 patients with type 1 and insulin-treated type 2 diabetes who were performing SMBG at suboptimal frequencies. Sites were cluster-randomized to “integrated strip-free” system (EXP group) or any “single-strip” system (CNL group). Testing frequency and HbA1c were measured at baseline, 12 weeks and 24 weeks. Results At week 24, the EXP group showed an increase in SMBG frequency from baseline of 4.17 tests/week (95% CI 2.76, 5.58) compared with an increase of 0.53 tests/week (95% CI −0.73, 1.79) among CNL patients, resulting in a between-group difference of 3.63 tests/week (p < 0.0002). Mixed-effects models for repeated measurements (MMRM) controlling for baseline frequency of testing, country and clinical site confirmed a higher SMBG testing frequency in the EXP group compared to the CNL group, with a between-group difference of 2.70 tests/week (p < 0.01). Univariate analysis showed greater HbA1c reductions in the EXP group than CNL group: −0.44% (95% CI −0.59, −0.29) vs. −0.13% (95% CI −0.27, 0.01), respectively, p < 0.0002. MMRM analyses confirmed these HbA1c reductions. A greater percentage of EXP than CNL patients achieved HbA1c reductions of ≥0.5%: 45.1% vs. 29.1%, respectively, p < 0.01. Conclusions The use of an integrated, strip-free SMBG system improved testing adherence and was associated with improvements in glycemic control.
Affiliations

Citations

Maran, A., Tschoepe, D., Di Mauro, M., Fisher, W. A., Loeffler, K., Vesper, I., Bloethner, S., Mast, O., Weissmann, J., Amann-Zalán, I., Moritz, A., Parkin, C. G., Kohut, T., & Cranston, I. (2014). Use of an integrated strip-free blood glucose monitoring system increases frequency of self-monitoring and improves glycemic control: Results from the ExAct study. Journal of Clinical and Translational Endocrinology, 1(4), 161-166. https://doi.org/10.1016/j.jcte.2014.08.003 (Original work published 2014)